CVS Health, which owns more than 9,600 retail pharmacies and 1,100 walk-in clinics, will offer a lower-cost generic version of the Adrenaclick epinephrine auto-injector, targeting Mylan after the ...

CVS’s deal to buy Aetna, one of the largest health insurers, has the potential for lowering costs, but also further concentrating key services among a few large companies. CVS Health announced ...

CVS decided to launch Adrenaclick® auto-injector on the market and sell the product for $109.99 per two-pack before potential discounts. Ms. Foulkes said most CVS customers will meet requirements for ...

After months of public criticism over the price hike of EpiPens, CVS will now stock a generic brand called Adrenaclick, another type of epinephrine auto-injector, for around one-sixth of the price.